Skip to main content
. 2022 Jun 1;26(6):558–565. doi: 10.5588/ijtld.21.0654

Table 3.

Summary of serum FSH and BMI in NC-005 *

Baseline Day 29 Day 57 = EOT Day 70




n Median n Median n Median n Median
FSH DS-TB: BdqLoadPa200Z 45 5.0 43 5.7 37 5.6 35 5.8
DS-TB: Bdq200Pa200Z 47 5.2 41 6.3 40 5.8 39 6.3
DR-TB: Bdq200Pa200MfxZ 36 5.6 37 6.1 38 6.4 37 5.7
DS-TB: HRZE 46 4.9 45 5.9 43 5.5 43 5.3
BMI DS-TB: BdqLoadPa200Z 43 19.3 43 19.4 37 19.6 35 19.8
DS-TB: Bdq200Pa200Z 45 19.2 41 19.7 40 20.0 39 20.2
DR-TB: Bdq200Pa200MfxZ 36 18.0 37 18.3 38 18.8 37 18.4
DS-TB: HRZE 46 17.9 45 18.7 43 18.9 43 19.1

* All patients in the Pa-containing arms (DS-TB and DR-TB) received 200 mg of Pa.

FSH = follicle stimulating hormone; BMI = body mass index; EOT = end-of-treatment; DS-TB = drug-susceptible TB; BDQ = bedaquiline; Pa = pretomanid; Z = pyrazinamide; DR-TB = drug-resistant TB; MFX = moxifloxacin; H = isoniazid; R = rifampin; E = ethambutol.